Literature DB >> 4351250

Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.

E Del Pozo, H Friesen, P Burmeister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4351250

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  19 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 2.  Pituitary-gonadal axis: historical notes.

Authors:  J Lindholm; E Husted Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 3.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

4.  The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.

Authors:  C Taşar; A Akdaş; Z Kirkali
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

5.  Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.

Authors:  D Helmerich; J E Altwein
Journal:  Urol Res       Date:  1976-11-10

6.  Bromocriptine treatment of acromegaly.

Authors:  M O Thorner; A Chait; M Aitken; G Benker; S R Bloom; C H Mortimer; P Sanders; A S Mason; G M Besser
Journal:  Br Med J       Date:  1975-02-08

7.  Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors:  H J Künzig; W Geiger; K D Schulz; K H Lose
Journal:  Arch Gynakol       Date:  1975

8.  Inhibition of thyrotropin and prolactin secretion by dopamine in man.

Authors:  F Massara; F Camanni; V Vergano; L Belforte; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

9.  The role of prolactin in the development of chronic progressive nephropathy in the rat.

Authors:  B Richardson; H Luginbühl
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-04-05

10.  Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.

Authors:  M T Hyyppä; V A Långvik; U K Rinne
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.